HIV Infection and Complications in Emergency Medicine

Emergency Medicine Clinics of North America

Volumn 26, Issue 2, 2008, Pages 367-387

  Marco, Catherine A ^a   Rothman, Richard E ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMITRIPTYLINE; AMPHOTERICIN B; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; ANTIRETROVIRUS AGENT; ATAZANAVIR; CIPROFLOXACIN; CLOTRIMAZOLE; CORTICOSTEROID; COTRIMOXAZOLE; DARUNAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; ENFUVIRTIDE; FLUCONAZOLE; FLUCYTOSINE; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; LAMIVUDINE; METHOTREXATE; NARCOTIC AGENT; NEVIRAPINE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; PHENYTOIN; PREDNISONE; PROTEINASE INHIBITOR; PYRIMETHAMINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; STEROID; SULFADIAZINE; TIPRANAVIR; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; CYSTITIS; DRUG CHOICE; EMERGENCY MEDICINE; EMERGENCY PHYSICIAN; EVIDENCE BASED MEDICINE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION COMPLICATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYELONEPHRITIS; REVIEW; UNITED STATES; URBAN AREA; URINALYSIS; URINARY TRACT INFECTION; VIRUS DIAGNOSIS;

EID: 41949120950     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2008.01.001     Document Type: Review

References (57)

1. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: 2003. Available at:. http://data.unaids.org/pub/EpiReport/2006/2006_EpiUpdate_en.pdf Accessed December 11, 2003
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Rev edition vol. 17 (2007), US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA)
3. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mort Wkly Rep 41 RR-17 (1993) 1
4. Franco-Paredes C., Tellez I., and del Rio C. Rapid HIV testing: a review of the literature and implications for the clinician. Curr HIV/AIDS Rep 3 (2006) 169-175
5. Branson B.M., Handsfield H.H., and Lampe M.A. Revised recommendations for HIV testing of adults, adolescents and pregnant women in health-care settings. MMWR Recomm Rep 55 RR14 (2006) 1-17
6. Branson B.M., Handsfield H.H., Lampe M.A., et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Available at:. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm Accessed February 11, 2007
7. Stobbe M. Study: majority of states bar HIV testing. Available at:. http://www.forbes.com/feeds/ap/2007/10/09/ap4203309.html Accessed October 10, 2007
8. Arbelaez C., Losina E., Wright E., et al. The barriers affecting health care providers' willingness to perform routine HIV testing in the emergency department. Ann Emerg Med 50 (2007) S118
9. Irvin C.B., Flagel B.T., and Fox J.M. The emergence department is not the ideal place for routine HIV testing. Ann Emerg Med 49 (2007) 722
10. Williams T.G., Reiter J., and Wright C.S. HIV testing in the emergency department: a practical guide. Available at:. http://www.edhivtestguide.org/ Accessed November 12, 2007
11. Rapid tests for HIV infection. The Medical Letter on Drugs and Therapeutics 45 (2003) 54-55
12. Rothman R.E. Current Centers for Disease Control and Prevention guidelines for HIV counseling, testing, and referral: critical role of and a call to action for emergency physicians. Ann Emerg Med 44 (2004) 31-42
13. Borg K.T. To test or not to test? HIV, emergency departments, and the new Centers for Disease Control and Prevention guidelines. Ann Emerg Med 49 (2007) 573-574
14. McKenna M. HIV testing: should the emergency department take part?. Ann Emerg Med 49 (2007) 190-192
15. Centers for Disease Control. HIV infection reporting. Available at:. http://www.cdc.gov/hiv/topics/surveillance/reporting.htm Accessed October 10, 2007
16. Sackoff J., McFarland J., Su S., et al. Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care. J Acquir Immune Defic Syndr Hum Retrovirol 19 4 (1998) 387-392
17. Whitcup S.M. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA 283 (2000) 653-658
18. Wei L.L., Park S.S., and Skiest D.J. Prevalence of visual symptoms among patients with newly diagnosed cytomegalovirus retinitis. Retina 22 (2002) 278-282
19. Stringer J.R., Beard C.B., Miller R.F., et al. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8 (2002) 891-896
20. NIH-UC Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia: Consensus statement for use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in AIDS. N Engl J Med 323 (1990) 1451-1457
21. Markowitz N., Hansen N.I., Hopewell P.C., et al. Incidence of tuberculosis in the United States among HIV-infected persons: the pulmonary complications of HIV infection study group. Ann Intern Med 126 (1997) 123-132
22. Perlman D.C., El-Sadr W.M., Nelson E.T., et al. Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. Clin Infect Dis 25 (1997) 242-246
23. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis in patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 47 (1998) 1-58
24. Blumberg H.M., Leonard Jr. M.K., and Jasmer R.M. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA 293 (2005) 2776-2784
25. Drugs for tuberculosis. The Medical Letter 5 (2007) 19
26. Rizzi E.B., Schinina V., Bellussi A., et al. Pulmonary mycosis in AIDS. Eur J Radiol 37 (2001) 42-46
27. Milei J., Grana D., Alonso G.F., et al. Cardiac involvement in acquired immunodeficiency syndrome: a review to push action. Clin Cardiol 21 (1998) 465-472
28. Chu W.W., Sosman J.M., and Stein J.H. Clinical cardiac manifestations of HIV infection: a review of current literature. WMJ 101 (2002) 39-45
29. Barbaro G., Fisher S.D., Giancaspro G., et al. HIV-associated cardiovascular complications: a new challenge for emergency physicians. Am J Emerg Med 19 (2001) 566-574
30. Bonacini M. Medical management of benign oesophageal disease in patients with human immunodeficiency virus infection. Dig Liver Dis 33 (2001) 294-300
31. Hunter P.R., and Nichols G. Epidemiology and clinical features of Cryptosporidium infections in immunocompromised patients. Clin Microbiol Rev 15 (2002) 145-154
32. Levin M.L., Palella F., Shah S., et al. HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis 37 (2001) E39
33. Golden M.R., Marra C.M., and Holmes K.K. Update of syphilis: resurgence of an old problem. JAMA 290 (2003) 1510-1514
34. Fleming D.T., and Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75 (1999) 3-17
35. Silva A., Glick N.R., Lyss S.B., et al. Implementing an HIV and sexually transmitted disease screening program in an emergency department. Ann Emerg Med 49 (2007) 564-572
36. Nasti G., Errante D., Santarossa S., et al. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. Drug Saf 20 (1999) 403-425
37. Treisman G., Fishman M., Lyketsos C., et al. Evaluation and treatment of psychiatric disorders associated with HIV infection. Res Publ Assoc Res Nerv Ment Dis 72 (1994) 239-250
38. Moses A., Nelson J., and Bagby G.C. The influence of human immunodeficiency virus-I on hematopoiesis. Blood 91 (1998) 1479-1495
39. Church J.A. Pediatric HIV in the emergency department. Clin Ped Emerg Med 8 (2007) 117-122
40. Palella F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338 (1998) 853-860
41. Department of Health and Human Services, and Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at:. www.hivatis.org Accessed February 8, 2008
42. Drugs for HIV infection. Med Lett 4 (2006) 67-76
43. Carpenter C.C., Cooper D.A., Fischl M.A., et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 283 (2000) 381
44. Warren K.J., Boxwell D.E., Kim N.Y., et al. Nevirapine-associated Stevens-Johnson syndrome. Lancet 351 (1998) 567
45. Hovanessian H.C. New developments in the treatment of HIV disease: an overview. Ann Emerg Med 33 (1999) 546-555
46. A once-daily combination tablet (Atripla) for HIV. Med Lett Drugs Ther 48 (2006) 78-79
47. Two once-daily fixed-dose NRTI combinations for HIV. Med Lett Drugs Ther 47 (2005) 19-20
48. US Department of Health and Human Services. Recommended HIV treatment regimens. Available at:. http://www.aidsinfo.nih.gov/ContentFiles/AboutHIVTreatmentGuidelines_FS_ en.pdf Accessed February 8, 2008
49. Ippolito G., Puro V., Heptonstall J., et al. Occupational human immunodeficiency virus infection in health care workers: worldwide cases through September 1997. Clin Infect Dis 28 (1999) 365-383
50. Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for postexposure prophylaxis. MMWR Morb Mortal Wkly Rep 50 RR-1 (2001) 1-52
51. Phillips K.A., Lowe R.A., Kahn J.G., et al. The cost-effectiveness of HIV testing of physicians and dentists in the United States. JAMA 271 (1994) 851-858
52. Gerberding J.L. Occupational exposure to HIV in health care settings. N Engl J Med 343 (2003) 826-833
53. Moran G.J. Emergency department management of blood and body fluid exposures. Ann Emerg Med 35 (2000) 47-62
54. Centers for Disease Control. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Available at:. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5011a1.htm Accessed February 8, 2008
55. Merchant R.C. Nonoccupational HIV postexposure prophylaxis: a new role for the emergency department. Ann Emerg Med 36 (2000) 366-375
56. McCausland J.B., Linden J.A., Degutis L.C., et al. Nonoccupational postexposure HIV prevention: emergency physicians' current practices, attitudes, and beliefs. Ann Emerg Med 42 (2003) 651-656
57. Katz M.H., and Gerberding J.L. The care of persons with recent sexual exposure to HIV. Ann Intern Med 128 (1998) 306-312